SCHEMBL7216489

SCHEMBL7216489

CC(C)(C)OC(=O)N(OC=O)C1CCNCC1

nearest known ligand 0.31

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.31
SLC6A4 P31645 3/20 0.31
SLC6A3 Q01959 2/20 0.31
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
GABRA1 P14867 1/20 0.31
TSHR P16473 1/20 0.31
GABRG2 P18507 1/20 0.31
NFKB1 P19838 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31
GABRA6 Q16445 1/20 0.31
CHRM2 P08172 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15328793 0.89 CHRM2 (0.34) NFKB1CHRM2CHRM1CHRM3
SCHEMBL28147671 0.77 SLC6A2 (0.33) SLC6A2SLC6A4SLC6A3
SCHEMBL6125628 0.76 GPR119 (0.34) SLC6A2SLC6A4SLC6A3GABRA1TSHR
SCHEMBL135183 0.76 HSD11B1 (0.42) SLC6A2SLC6A4SLC6A3GABRA1TSHR
SCHEMBL29261903 0.76 GABRA1 (0.32) LMNACYP3A4GABRA1TSHRGABRG2
SCHEMBL15021681 0.74 SLC6A4 (0.32) SLC6A2SLC6A4SLC6A3GABRA1TSHR
SCHEMBL13144562 0.74 SLC6A4 (0.38) SLC6A2SLC6A4SLC6A3CHRM3
Hydrochloric Acid SCHEMBL8054576 0.74 HSD11B1 (0.41) SLC6A2SLC6A4SLC6A3GABRA1TSHR
Hydrochloric Acid SCHEMBL18824762 0.74 HSD11B1 (0.41) SLC6A2SLC6A4SLC6A3GABRA1TSHR
SCHEMBL27740053 0.73 SLC6A4 (0.38) SLC6A2SLC6A4SLC6A3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed